A carregar...
Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell Carcinoma
The recent FDA approval of multiple new pharmaceutical agents for metastatic renal cell carcinoma (RCC) has left physicians with several options for first- and second- line therapy. With limited head-to-head comparisons, however, there is a paucity of evidence to recommend the use of one agent over...
Na minha lista:
| Publicado no: | Transl Cancer Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4986829/ https://ncbi.nlm.nih.gov/pubmed/27540511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tcr.2016.06.05 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|